JPM gains South Korea OTC licence

JP Morgan has acquired a licence to market and trade OTC derivatives in South Korea, allowing the JP Morgan Securities Far East Seoul Branch to participate in the derivatives and securitised derivatives markets, including structured products.

The licence allows the bank to market and trade onshore OTC derivatives and products in Korean won across asset classes, and to act as a liquidity provider for equity-linked warrants.

Although JP Morgan can trade and market structured products onshore, it

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

If you already have an account, please sign in here.


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here